| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
TET2 |
| 2 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
TET2 |
| 3 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
TET2 |
| 4 |
35064935 |
10.1111/his.14619 |
2022 |
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. |
TET2 |
| 5 |
35255774 |
10.1080/15548627.2022.2048432 |
2022 |
TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. |
TET2 |
| 6 |
35401516 |
10.3389/fimmu.2022.842439 |
2022 |
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. |
TET2 |
| 7 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
TET2 |
| 8 |
36048893 |
10.1093/ajcp/aqac104 |
2022 |
Systemic Presentation of Somatic TET2 Mutated B-Cell Lymphoma in a Child With Kabuki Syndrome and a Germline KMT2D Variant. |
TET2 |
| 9 |
33413063 |
10.2174/1568009620666210106122750 |
2021 |
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL). |
TET2 |
| 10 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
TET2 |
| 11 |
33432228 |
10.1038/s41590-020-00827-8 |
2021 |
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. |
TET2 |
| 12 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
TET2 |
| 13 |
33650043 |
10.1007/s00428-021-03071-z |
2021 |
Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring. |
TET2 |
| 14 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
TET2 |
| 15 |
33939500 |
10.1177/10668969211013402 |
2021 |
A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. |
TET2 |
| 16 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
TET2 |
| 17 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
TET2 |
| 18 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
TET2 |
| 19 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
TET2 |
| 20 |
34449978 |
10.1002/dc.24861 |
2021 |
Angioimmunoblastic T-cell lymphoma diagnosed from pleural fluid by integration of morphologic, immunophenotypic, and molecular findings. |
TET2 |
| 21 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
TET2 |
| 22 |
34590470 |
10.52586/4970 |
2021 |
Methylation alterations and advance of treatment in lymphoma. |
TET2 |
| 23 |
34621263 |
10.3389/fimmu.2021.688493 |
2021 |
Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. |
TET2 |
| 24 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
TET2 |
| 25 |
31028364 |
10.1038/s41379-019-0279-8 |
2020 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
TET2 |
| 26 |
32127923 |
10.1177/1758835919900856 |
2020 |
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. |
TET2 |
| 27 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
TET2 |
| 28 |
32469082 |
10.1002/cncr.32866 |
2020 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
TET2 |
| 29 |
32518946 |
10.1182/blood.2020005844 |
2020 |
Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. |
TET2 |
| 30 |
32598477 |
10.1182/bloodadvances.2019001350 |
2020 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
TET2 |
| 31 |
33160401 |
10.1186/s13148-020-00962-x |
2020 |
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma. |
TET2 |
| 32 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
TET2 |
| 33 |
34667996 |
10.21037/aol-20-20 |
2020 |
Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond. |
TET2 |
| 34 |
29629950 |
10.1097/PAI.0000000000000644 |
2019 |
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. |
TET2 |
| 35 |
30623224 |
10.1007/s00347-018-0840-8 |
2019 |
[New molecular pathological strategies for malignant iris tumors]. |
TET2 |
| 36 |
30632835 |
10.1080/10428194.2018.1516878 |
2019 |
Descriptive analysis of genetic aberrations and cell of origin in Richter transformation. |
TET2 |
| 37 |
30683910 |
10.1038/s41375-019-0380-5 |
2019 |
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. |
TET2 |
| 38 |
30952970 |
10.1038/s41379-019-0254-4 |
2019 |
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2<sup>R172</sup> mutations. |
TET2 |
| 39 |
31123138 |
10.1136/jclinpath-2019-205727 |
2019 |
Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis. |
TET2 |
| 40 |
31311407 |
10.1080/15384047.2019.1638670 |
2019 |
Somatic mutations in <i>KMT2D</i> and <i>TET2</i> associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders. |
TET2 |
| 41 |
31594013 |
10.1055/a-0597-7606 |
2019 |
[Current standard in diagnostic and therapy of peripheral T-cell lymphoma]. |
TET2 |
| 42 |
29895903 |
10.1038/s41408-018-0089-0 |
2018 |
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. |
TET2 |
| 43 |
30274972 |
10.1158/2159-8290.CD-18-0657 |
2018 |
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. |
TET2 |
| 44 |
31938438 |
NA |
2018 |
Secondary mixed phenotype acute leukemia following chemotherapy for diffuse large B-cell lymphoma: a case report and review of the literature. |
TET2 |
| 45 |
27921272 |
10.1007/s12185-016-2159-z |
2017 |
BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma. |
TET2 |
| 46 |
28148900 |
10.18632/oncotarget.14846 |
2017 |
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling. |
TET2 |
| 47 |
28487787 |
10.1155/2017/5083463 |
2017 |
EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>. |
TET2 |
| 48 |
28691928 |
10.1172/JCI92026 |
2017 |
Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. |
TET2 |
| 49 |
26697989 |
10.1016/j.critrevonc.2015.11.004 |
2016 |
Myeloproliferative neoplasms: Current molecular biology and genetics. |
TET2 |
| 50 |
27055146 |
10.1097/MOH.0000000000000249 |
2016 |
The many layers of epigenetic dysfunction in B-cell lymphomas. |
TET2 |
| 51 |
27203213 |
10.18632/oncotarget.9400 |
2016 |
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders. |
TET2 |
| 52 |
26551667 |
10.1038/ng.3442 |
2015 |
The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. |
TET2 |
| 53 |
24345752 |
10.1182/blood-2013-10-531509 |
2014 |
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. |
TET2 |
| 54 |
24413734 |
10.1038/ng.2873 |
2014 |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. |
TET2 |
| 55 |
23298878 |
10.1097/MOH.0b013e32835d82fe |
2013 |
Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications. |
TET2 |
Datasets
Models
